Compiled by the ENCLAI research team following a documented methodology · Editorial oversight: Dr Natalya Mathur, Founder · Data last updated: (UTC)

Cutaneous and mucocutaneous leishmaniasis in Ecuador: 2026 cases and outbreak reports

Reported cutaneous and mucocutaneous leishmaniasis surveillance for Ecuador (ECU) — — latest record 2026-10-13

What the 2026 data shows

As of 24 October 2026, Ecuador has reported 660 cutaneous and mucocutaneous leishmaniasis cases in 2026, as published by Ecuador MSP. No 2025 figure has been reported.

Of the 4 countries reporting cutaneous and mucocutaneous leishmaniasis to ENCLAI in 2026, Ecuador accounts for 15.3% of reported cases and ranks 2 by case count.

ENCLAI has logged 23 surveillance records for cutaneous and mucocutaneous leishmaniasis in Ecuador in 2026, with the most detailed reporting in Jun 2026 (22 records). 1 of those arrived in the last 30 days; the case counts run to 2026-10-24. 2 distinct surveillance sources reported this pair in 2026.

Reporting authorities for these counts: Ecuador MSP — Gaceta Vectorial (ETV) subnational

The daily disease brief

One email a day: what changed in official disease reporting worldwide, with the source named for every number. Reported facts only — no forecasts and no interpretation.

Double opt-in — we send a confirmation link and nothing else until you click it. One-click unsubscribe on every email. See our privacy notice.

Surveillance summary

2026 cases (YTD)
660
2025 cases (full year)
not reported
Baseline avg (3yr)
N/A
Trend (2025)
—
No 2025 figure

Reported cases by year, Ecuador

YearReported casesShare of worldwide reports
2023 not reported —
2024 not reported —
2025 not reported —
2026 (year to date) 660 15.3%

Reporting bounds and case definitions vary; historical baselines are a separate comparison measure. Worldwide share compares this country's reported figure with the sum of all countries reporting cutaneous and mucocutaneous leishmaniasis to ENCLAI for that year. "Incomplete year" means our sources cover less than ten months of that year, so no full-year figure is shown; "outbreak total to date" is a running total since an outbreak began, not a count for one year.

Surveillance records logged in 2026

MonthRecordsReporting sources
Jun 2026222
Oct 202611

A record is one dated surveillance publication or one row of an official table; a month with many records is a month with detailed reporting, not necessarily more cases. 1 records were logged in the last 30 days.

Sub-national reporting, 2026

Areas within Ecuador with the most cutaneous and mucocutaneous leishmaniasis records this year:

AreaRecords
Azuay1
Bolívar1
Canar1
Chimborazo Province1
Cotopaxi1

Cutaneous and mucocutaneous leishmaniasis in other countries, 2026

Country2026 casesTrend
Colombia 3,543
China 95
Lebanon 5

Other diseases reported in Ecuador, 2026

Disease2026 casesTrend
Malaria (unspecified) 287
Chagas disease 73
Leishmaniasis 1

Questions about this page

How many cutaneous and mucocutaneous leishmaniasis cases has Ecuador reported in 2026?
As of 24 October 2026, Ecuador has reported 660 cutaneous and mucocutaneous leishmaniasis cases in 2026, as published by Ecuador MSP. No 2025 figure has been reported.
Where does Ecuador publish cutaneous and mucocutaneous leishmaniasis surveillance data?
The counts on this page were published by Ecuador MSP — Gaceta Vectorial (ETV) subnational. ENCLAI compiles and normalises them and is not affiliated with these authorities.

About this data

Figures are reported case counts as published by the originating health authorities, compiled by ENCLAI from 444 verified surveillance sources. Ecuador figures reflect the reporting available to ENCLAI; reporting periods and case definitions differ between sources, and a missing report does not establish zero cases. ENCLAI holds cutaneous and mucocutaneous leishmaniasis records for Ecuador dated from 2024. How we verify and update data: methodology & Trust Center · understanding case counts.

Track cutaneous and mucocutaneous leishmaniasis in Ecuador live — alerts, exports and sub-national drill-down: start a 7-day free trial or request a demo.

The daily disease brief

One email a day: what changed in official disease reporting worldwide, with the source named for every number. Reported facts only — no forecasts and no interpretation.

Double opt-in — we send a confirmation link and nothing else until you click it. One-click unsubscribe on every email. See our privacy notice.